BIM
ENZN

BlackRock Investment Management’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

BlackRock Investment Management’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-129,535
Closed -$133K – 4124
2014
Q1 		$133K Sell
129,535
-2,058
-2% -$2.13K ﹤0.01% 3276
2013
Q4 		$153K Sell
131,593
-3,775
-3% -$5.81K ﹤0.01% 3244
2013
Q3 		$227K Buy
135,368
+231
+0.2% +$427 ﹤0.01% 3162
2013
Q2 		$270K Buy
+135,137
New +$396K ﹤0.01% 3108

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock Investment Management's ENZN Position: Q2 2014 in Review

BlackRock Investment Management sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q2 2014, closing a stake of 129,535 shares — an estimated $133K sold.

BlackRock Investment Management first reported a position in ENZN in Q2 2013 and held it in 4 quarters. The position peaked at $270K in Q2 2013. 67 funds tracked by Wall St. Rank hold ENZN as of Q2 2014.

  • BlackRock Investment Management reported no remaining ENZON PHARMACEUTICALS INC position as of Q2 2014 after selling out during the quarter.
  • BlackRock Investment Management sold 129,535 ENZON PHARMACEUTICALS INC shares in Q2 2014, an estimated $133K.
  • BlackRock Investment Management first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 4 quarters.
  • BlackRock Investment Management's ENZON PHARMACEUTICALS INC position peaked at $270K in Q2 2013.
  • 67 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q2 2014.

Based on BlackRock Investment Management's 13F filing for Q2 2014, filed 6 Aug 2014.